Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

231
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
231
Methods of reducing fever01:22

Methods of reducing fever

1.2K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.2K
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

400
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
400
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

165
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
165
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Hypothermia and Mortality Among Children in the Emergency Department.

Pediatrics·2026
Same author

Clinician Suspicion for Lyme Disease and Clinical Decision-Making in Children with Monoarthritis.

medRxiv : the preprint server for health sciences·2026
Same author

Improving Diagnostic Quality of Anogenital Photodocumentation in Emergency Department Evaluations for Acute Child Sexual Assault.

Pediatric quality & safety·2026
Same author

Derivation and validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) score: A prospective cohort study.

Journal of hospital medicine·2025
Same author

Urine Dipstick for the Diagnosis of Urinary Tract Infection in Febrile Infants Aged 2 to 6 Months.

Pediatrics·2025
Same author

Improving acute care for Primary Mitochondrial Disease: Development of a publicly available clinical care pathway.

Molecular genetics and metabolism·2025
Same journal

Downward Trends in Neonatal Hepatitis B Vaccine Uptake: 2021 to 2025.

Hospital pediatrics·2026
Same journal

Use of Stigmatizing Language in Pediatric Clinician Notes.

Hospital pediatrics·2026
Same journal

Lead Locally, Impact Nationally: Roles and Responsibilities for Site PI in PHM Research.

Hospital pediatrics·2026
Same journal

Trends, Outcomes, and Resource Use of Pediatric Tracheostomy in Alberta: A Cohort Study.

Hospital pediatrics·2026
Same journal

Too Complex to Treat? Equity in Access to Inpatient Pediatric Pain Rehabilitation.

Hospital pediatrics·2026
Same journal

Caregiver Perspectives on Preventing Future Hospitalizations for Children With Medical Complexity.

Hospital pediatrics·2026
関連記事をすべて見る

関連する実験動画

Updated: Jan 8, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.3K

新生児早期発熱乳児における静脈内抗生物質使用を減らすための質改善イニシアチブ

Jessica M Kelly1,2, Laura F Sartori1,2, Payal Gala1,2

  • 1Division of Emergency Medicine, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Hospital pediatrics
|December 21, 2025
PubMed
まとめ
この要約は機械生成です。

この質改善プロジェクトは、最新ガイドラインと炎症マーカー検査の実施により、発熱乳児における抗生物質使用を成功裏に削減しました。プロカルシトニン（PCT）検査が大幅に増加し、幼い子供たちの安全なケアにつながりました。

キーワード:
新生児乳児発熱抗生物質質改善プロカルシトニンガイドライン小児科感染症

さらに関連する動画

Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

60.8K
A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
09:57

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit

Published on: July 13, 2019

13.7K

関連する実験動画

Last Updated: Jan 8, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.3K
Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

60.8K
A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
09:57

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit

Published on: July 13, 2019

13.7K

科学分野:

  • 小児科; 感染症; 質改善

背景:

  • 2021年の米国小児科学会（AAP）ガイドラインでは、プロカルシトニン（PCT）などの炎症マーカーを使用して、抗生物質投与を免除できる低リスクの発熱乳児を特定することが推奨されています。
  • 質改善（QI）プロジェクトは、救急部門の22〜56日齢の発熱乳児を対象としました。

研究 の 目的:

  • ベースライン46%から1年以内に36%まで、発熱乳児への抗生物質投与を安全に減らすこと。
  • 抗生物質使用の削減が、さまざまな人種、民族、および好ましい言語間で公平であることを保証すること。

主な方法:

  • 多職種チームが、臨床経路の更新、臨床意思決定支援（CDS）、および教育を含む介入を実施しました。
  • 4回のPlan-Do-Study-Actサイクルが使用され、統計的プロセス管理により抗生物質使用とPCTの結果が分析されました。
  • 菌血症または細菌性髄膜炎の見逃しが、バランス指標として機能しました。

主要な成果:

  • 抗生物質使用は46%から33%に減少し、特に22〜28日齢の乳児（86%から43%）で顕著でした。
  • プロカルシトニン（PCT）の使用は4%から97%に増加し、IM検査に差はありませんでした。
  • 抗生物質使用は、非ヒスパニック系白人乳児で減少しましたが、非ヒスパニック系黒人乳児では減少しませんでした。菌血症または髄膜炎の見逃し症例はありませんでした。

結論:

  • 臨床経路、CDS、および教育を統合したQIフレームワークは、AAPガイドラインに沿って、22日齢の早期発熱乳児における抗生物質曝露を効果的に減少させました。
  • 今後の取り組みでは、すべての乳児集団にわたる抗生物質曝露の公平な削減を保証する必要があります。